Children's Medical Center Corporation

Children's Medical Center Corporation

Children's Medical Center Corporation is the parent entity and sole member of Boston Children's Hospital, a Harvard Medical School teaching affiliate. Philip Rotner established the investment office in 2010, professionalizing what had previously been a more passive treasury function. The hospital's clinical and research operations — consistently ranked among the top pediatric centers in the United States — generate the clinical revenue and philanthropic gifts that build the asset base Rotner oversees. Kevin Churchwell serves as president and CEO of both CMCC and the hospital, a dual role that ties investment governance directly to the health system's operating leadership. The investment office deploys capital across a deliberately broad mandate: venture capital and growth equity dominate the allocation, but the portfolio also includes buyout funds, distressed debt, special situations, and a dedicated real estate sleeve managed through Fenmore Realty Corporation. The real estate holdings span the hospital's main Longwood Avenue campus, a satellite facility in Waltham, and the Franciscan Hospital for Children campus in Brighton. On the venture side, CMCC's strategy is distinctive — Rotner uses the hospital's clinical research footprint and Harvard Medical School relationships to diligence life-science managers and co-invest alongside firms where Timothy Springer or similar scientific founders act as licensors. The office maintains a short-term capital pool for liquidity management alongside the long-term portfolio. Rotner sits on the investment committee of the Massachusetts Pension Reserves Investment Management Board, a position that places him inside the $100-billion-plus public pension system's manager selection process — an unusual source of institutional deal flow for a hospital endowment. He also serves as a strategic advisor to Windrose Advisors, a Boston-based multifamily office, creating a second channel into private investment opportunities that other endowments of CMCC's size rarely access. Fund commitments share portfolio space with direct co-investments and early-stage seed checks into companies that sometimes emerge directly from Boston Children's Hospital's own research community. Where most hospital endowments outsource asset allocation to an OCIO or a small in-house team running a 60/40 portfolio, CMCC operates more like a foundation with an embedded venture-capital platform. The direct co-investment capability — Rotner can write checks into seed and start-up rounds, not just fund commitments — makes the office an active participant in Boston's life-science ecosystem rather than a passive limited partner. The philanthropic side is structurally separated through Boston Children's Hospital Trust and the CHMC Anesthesia Foundation, entities that raise charitable dollars without commingling them into the investment pool, preserving a clean boundary between development activities and the investment office's fiduciary mandate.